このページのURL

この文献を取り寄せる

<電子ブック>
DeVita, Hellman, and Rosenberg's Cancer : Principles & Practice of Oncology

10th ed.
出版者 (Philadelphia : Wolters Kluwer Health)
出版年 2015
大きさ 1 online resource (2280 pages)
書誌ID MC00033324

所蔵情報を非表示

eBook オンライン資料

MC000040981
Ebook Central Perpetual, DDA and Subscription Titles 9781496324672

書誌詳細を非表示

一般注記 Cancer Principles & Practice of Oncology -- CONTRIBUTORS -- PREFACE -- Acknowledgments -- CONTENTS -- PART I Principles of Oncology -- 1 Cancer Genome -- introduction -- CANCER GENES AND THEIR MUTATIONS -- IDENTIFICATION OF CANCER GENES -- SOMATIC ALTERATION CLASSES DETECTED BY CANCER GENOME ANALY SIS -- PATHWAY-ORIENTED MODELS OF CANCER GENOME ANALY SIS -- NETWORKS OF CANCER GENOME PROJECTS -- THE GENOMIC LANDSCAPE OF CANCERS -- INTEGRATIVE ANALY SIS OF CANCER GENOMICS -- THE CANCER GENOME AND THE NEW TAXONOMY OF TUMORS -- CANCER GENOMICS AND DRUG RESISTANCE -- PERSPECTIVES OF CANCER GENOME ANALY SIS -- Acknowledgments -- 2 Hallmarks of Cancer: An Organizing Principle for Cancer Medicine -- Introduction -- HALLMARK CAPABILITIES, IN ESSENCE -- TWO UBIQUITOUS CHARACTERISTICS FACILITATE THE ACQUISITION OF HALLMARK CAPABILITIES -- THE CONSTITUENT CELL TYPES OF THE TUMOR MICROENVIRONMENT -- THERAPEUTIC TARGETING OF THE HALLMARKS OF CANCER -- CONCLUSION AND A VISION FOR THE FUTURE -- Acknowledgment -- 3 Molecular Methods in Cancer -- Applications of Molecular Diagnostics in Oncology -- The Clinical Molecular Diagnostics Laboratory: Rules and Regulations -- Specimen Requirements for Molecular Diagnostics -- Molecular Diagnostics Testing Process -- Technologies -- PART II Etiology and Epidemiology of Cancer -- Section 1 Etiology of Cancer -- 4 Tobacco -- introduction -- EPIDEMIOLOGY OF TOBACCO AND CANCER -- CARCINOGENS IN TOBACCO PRODUCTS AND PROCESSES OF CANCER DEVELOPMENT -- 5 Oncogenic Viruses -- PRINCIPLES OF TUMOR VIROLOGY -- PAPILLOMAVIRUSES -- POLYOMAVIRUSES -- EPSTEIN-BARR VIRUS -- KAPOSI's SARCOMA HERPESVIRUS -- ANIMAL AND HUMAN RETRO VIRUSES -- HEPATITIS VIRUSES -- CONCLUSION -- 6 Inflammation -- Introduction -- MOLECULAR BASIS OF INFLAMMATION -- ROLE OF INFLAMMATION IN TRANSFORMATION -- ROLE OF INFLAMMATION IN SURVIVAL
ROLE OF INFLAMMATION IN PROLIF ERATION -- ROLE OF INFLAMMATION IN INVASION -- ROLE OF INFLAMMATION IN ANGIOGENESIS -- ROLE OF INFLAMMATION IN META STASIS -- EPIGENETIC CHANGES AND INFLAMMATION -- ROLE OF INFLAMMATION IN CANCER DIAGNOSIS -- INFLAMMATION AND GENOMICS -- INFLAMMATION AND TARGETED THERAPIES -- CONCLUSIONS -- 7 Chemical Factors -- Introduction -- THE NAT URE OF CHEMICAL CARCINOGENS: CHEMISTRY AND META BOLISM -- ANIMAL MODEL SYSTEMS AND CHEMICAL CARCINOGENESIS -- MOLECULAR EPIDEMIOLOGY, CHEMICAL CARCINOGENESIS, AND CANCER RISK IN HUMAN POPULATION S -- ARISTOLO CHIC ACID AND UROT HELIAL CANCERS AS A MODEL FOR IDENTIFYING HUMAN CARCINOGENS -- 8 Physical Factors -- INTRODUCTION -- IONIZING RADIATION -- ULTRAVIOLET LIGHT -- RADIOFREQUENCY AND MICROWAVE RADIATION -- ELECTROMAGNETIC FIELDS -- ASBESTOS -- NANOPARTICLES -- 9 Dietary Factors -- Introduction -- METHODOLOGIC CHALLENGES -- THE ROLE OF INDIVIDUAL FOOD AND NUTRIENTS IN CANCER ETIOLOGY -- OTHER FOODS AND NUTRIENTS -- DIETARY PATTERNS -- DIET DURING THE EARLY PHASES OF LIFE -- DIET AFTER A DIAGNOSIS OF CANCER -- SUMMARY -- LIMITATIONS -- FUTURE DIRECTIONS -- RECOMMENDATIONS -- 10 Obesity and Physical Activity -- INTRODUCTION -- BREAST CANCER -- COLON AND RECTAL CANCER -- ENDOMETRIAL CANCER -- ADENOCARCINOMA OF THE ESOPHAGUS -- KIDNEY/RENAL CELL CANCER -- PANCREATIC CANCER -- GALLBLADDER CANCER -- NON-HODGKIN LYMPHOMA -- PROSTATE CANCER -- LUNG CANCER -- OVARIAN CANCER -- CONCLUSIONS -- Section 2 Epidemiology of Cancer -- 11 Epidemiologic Methods -- Introduction -- ANALYTICAL STUDIES -- INTERPRETATION OF EPIDEMIOLOGIC FINDINGS -- CANCER OUTCOMES RESEARCH -- MOLECULAR EPIDEMIOLOGY -- 12 Trends in United States Cancer Mortality -- INTRODUCTION -- CANCER SURVEILLANCE SYSTEMS -- MAKING SENSE OF CANCER TRENDS -- TRENDS IN CANCER RISK FACTORS AND SCREENING -- CANCER INCIDENCE AND MORTALITY
PREDICTING FUTURE CANCER TRENDS -- PART III Cancer Therapeutics -- 13 Essentials of Radiation Therapy -- INTRODUCTION -- BIOLOGIC ASPECTS OF RADIATION ONCOLOGY -- FACTORS THAT AFFECT RADIATION RESPONSE -- DRUGS THAT AFFECT RADIATION SENSITIVITY -- RADIATION PHYSICS -- TREATMENT PLANNING -- OTHER TREATMENT MODALITIES -- CLINICAL APPLICATIONS OF RADIATION THERAPY -- TREATMENT INTENT -- FRACTIONATION -- ADVERSE EFFECTS -- PRINCIPLES OF COMBINING ANTICANCER AGENTS WITH RADIATION THERAPY -- 14 Cancer Immunotherapy -- Introduction -- HUMAN TUMOR ANTIGENS -- HUMAN CANCER IMMUNOTHERAPIES -- 15 Pharmacokinetics and Pharmacodynamics of Anticancer Drugs -- INTRODUCTION -- PHARMACOKINETIC CONCEPTS -- PHARMACODYNAMIC CONCEPTS -- VARIABILITY IN PHARMACOKINETICS/ PHARMACODYNAMICS -- DOSE-ADAPTATION USING PHARMACOKINETIC/PHARMACODYNAMIC PRINCIPLES -- 16 Pharmacogenomics -- Introduction -- PHARMACOGENOMICS OF TUMOR RESPONSE -- PHARMACOGENOMICS OF CHEMOTHERAPY DRUG TOXICITY -- CONCLUSIONS AND FUTURE DIRECTIONS -- 17 Alkylating Agents -- PERSPECTIVES -- CHEMISTRY -- CLASSIFICATION -- CLINICAL PHARMACOKINETICS/ PHARMACODYNAMICS -- THERAPEUTIC USES -- TOXICITIES -- COMPLICATIONS WITH HIGH-DOSE ALKYLATING AGENT THERAPY -- ALKYLATING AGENT-STEROID CONJUGATES -- DRUG RESISTANCE AND MODULATION -- RECENT DEVELOPMENTS -- 18 Platinum Analogs -- Introduction -- HISTORY -- PLATINUM CHEMISTRY -- PLATINUM COMPLEXES AFTER CISPLATIN -- MECHANISM OF ACTION -- CELLULAR RESPONSES TO PLATINUM-INDUCED DNA DAMAGE -- IS DNA THE ONLY TARGET? -- MECHANISMS OF RESISTANCE -- CLINICAL PHARMACO LOGY -- FORMULATION AND ADMINISTRATION -- TOXICITY -- 19 Antimetabolites -- ANTIFOLATES -- 5-FLUOROPYRIMIDINES -- CAPECITABINE -- CYTARABINE -- GEMCITABINE -- 6-THIOPURINES -- FLUDARABINE -- CLADRIBINE -- CLOFARABINE -- 20 Topoisomerase Interactive Agents
CLASSIFICATION, BIOCHEMICAL, AND BIOLOGIC FUNCTIONS OF TOPOISOMERASES -- TOPOISOMERASE INHIBITORS AS INTERFACIAL POISONS -- Topoisomerase I Inhibitors : Camptothecins and Beyond -- TOPOISOMERASE II INHIBITORS: INTERCALATORS AND NONINTERCALATORS -- THERAPY-RELATED SECONDARY ACUTE LEUKEMIA -- FUTURE DIRECTIONS -- 21 Agents -- MICROTUBULES -- TAXANES -- VINCA ALKALOIDS -- MICROTUBULE ANTAGONISTS -- MITOTIC MOTOR PROTEIN INHIBITORS -- MECHANISMS OF RESISTANCE TO MICROTUBULE INHIBITORS -- 22 Kinase Inhibitors as Anticancer Drugs -- INTRODUCTION -- EARLY SUCCESSES: TAR GETING CANCERS WITH WELL-KNOWN KINASE MUTATI ONS (BCR-ABL, KIT, HER2) -- DIRECTLY TARGETING THE PI3K PATH WAY -- COMBINATIONS OF KINASE INHIBITORS TO INDUCT RESPONSE AND PREVENT RESISTANCE -- SPECULATI ONS ON THE FUTURE ROLE OF KINASE INHIBITORS IN CANCER MEDICINE -- 23 Histone Deacetylase Inhibitors and Demethylating Agents -- INTRODUCTION -- EPIGENETIC ABNORMALITIES AND GENE EXPRESSION CHANGES IN CANCER -- HISTONE DEACETYLASE INHIBITORS -- EPIGENETIC THERAPY FOR HEMATOLOGIC MALIGNANCIES -- NEW APROACHES TO EPIGENETIC THERAPY -- 24 Proteasome Inhibitors -- BIOCHEMISTRY OF THE UBIQUITIN-PROTEASOME PATHWAY -- PROTEASOME INHIBITORS -- PROTEASOME INHIBITORS IN CANCER -- 25 Poly (ADP-ribose) Polymerase Inhibitors -- INTRODUCTION -- CELLULAR DNA REPAIR PATHWAYS -- THE DEVELOPMENT OF PARP INHIBITORS -- BRCA1 AND BRCA2 MUTATIONS AND DNA REPAIR -- PARP -1 INHIBITION AS A SYNTHETIC LETHAL THERAPEUTIC STRATE GY FOR THE TREAT MENT OF BRCA -DEFICIENT CANCERS -- INITIAL CLINICAL RESULTS TESTING SYNTHETIC LETHALITY OF PARP INHIBITORS AND BRCA MUTATION -- THE USE OF PARP INHIBITORS IN SPORADIC CANCERS -- MECHANISMS OF RESISTANCE TO PARP INHIBITORS -- PROSPECTS -- 26 Miscellaneous Chemotherapeutic Agents -- HOMOHARRINGTONINE AND OMACETAXINE -- L-ASPARAGINASE -- BLEOMYCIN -- PROCARBAZINE
SIROLIMUS AND TEMSIROLIMUS -- VISMODEGIB -- ADO-TRASTUZUMAB EMTANSINE -- SIROLIMUS AND TEMSIROLIMUS -- EVEROLIMUS -- THALIDOMIDE, LENALIDOMIDE, AND POMALIDOMIDE -- 27 Hormonal Agents -- Introduction -- SELECTIVE ESTROGEN RECEPTOR MODULATORS -- AROMATASE INHIBITORS -- GONADOTROPIN-RELEASING HORMONE ANALOGS -- GONADOTROPIN-RELEASING HORMONE ANTAGONISTS -- ANTIANDROGENS -- NOVEL ANTIANDROGENS -- OTHER SEX STEROID THERAPIES -- OTHER HORMONAL THERAPIES -- 28 Antiangiogenesis Agents -- INTRODUCTION -- UNDERSTANDING THE ANGIOGENIC PROCESS -- DRUG DEVELOPMENT OF ANGIOGENESIS INHIBITORS -- CLINICAL UTILITY OF APPROVED ANTIANGIOGENIC AGENTS IN CANCER THERAPY -- COMBINATION THERAPIES -- BIOMARKERS OF ANTIANGIOGENIC THERAPY -- RESISTANCE TO ANTIANGIOGENIC THERAPY -- 29 Monoclonal Antibodies -- INTRODUCTION -- IMMUNOGLOBULIN STRUCTURE -- MODIFIED ANTIBODY-BASED MOLECULES -- FACTORS REGULATING ANTIBODY-BASED TUMOR TARGETING -- UNCONJUGATED ANTIBODIES -- ALTERING SIGNAL TRANSDUCTION -- IMMUNOCONJUGATES -- ANTIBODIES APPROVED FOR USE IN SOLID TUMORS -- ANTIBODIES USED IN HEMATOLOGIC MALIGNANCIES -- CONCLUSION -- 30 Assessment of Clinical Response -- INTRODUCTION -- ASSESSING RESPONSE -- ALTERNATE RESPONSE CRITERIA -- DETERMINING OUTCOME -- PART IV Cancer Prevention and Screening -- 31 Tobacco Use and the Cancer Patient -- Introduction -- NEUROBIOLOGY OF TOBACCO DEPENDENCE -- TOBACCO USE PREVALENCE AND THE EVOLUTION OF TOBACCO PRODUCTS -- TOBACCO USE BY THE CANCER PATIENT -- THE CLINICAL EFFECTS OF SMOKING ON THE CANCER PATIENT -- ADDRESSING TOBACCO USE BY THE CANCER PATIENT -- FUTURE CONSIDERATIONS -- 32 Role of Surgery in Cancer Prevention -- INTRODUCTION -- PATIENTS AT HIGH RISK FOR BREAST CANCER -- HEREDITARY DIFFUSE GASTRIC CANCER -- SURGICAL PROPHYLAXIS OF HEREDITARY OVARIAN AND ENDOMETRIAL CANCER -- HEREDITAR Y ENDOMETRIAL CANCER (LYNCH SYNDRO ME)
GYNECOLOGIC CANCER RISK IN VERY RARE HEREDITARY CANCER SYNDRO MES
Select references are available in the print book. ALL REFERENCES FOR DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 10th edition ARE AVAILABLE ONLINE AT LWWHealthLibrary.com/oncology. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 10th edition has garnered universal acclaim as the world's definitive, standard-setting oncology reference. More than 400 respected luminaries explore today's most effective strategies for managing every type of cancer by stage of presentation - discussing the role of all appropriate therapeutic modalities as well as combined-modality treatments. This multidisciplinary approach will help your cancer team collaboratively face the toughest clinical challenges and provide the best possible care for every cancer patient.* Access the complete contents online or on your mobile device, with quarterly updates reflecting late-breaking developments in cancer care, free for the first year on LWW Health Library.*Take full advantage of the latest advances with brand-new chapters on Hallmarks of Cancer, Molecular Methods in Cancer, Oncogenic Viruses, Cancer Screening, and new sections on Genetic testing and counseling for cancer, plus comprehensive updates throughout - including coverage of the newest biologic therapies.*Make optimal, well-coordinated use of all appropriate therapies with balanced, multidisciplinary advice from a surgeon, a medical oncologist, and a radiation oncologist in each major treatment chapter.*Review the latest molecular biology knowledge for each type of cancer and its implications for improved management.*Make the best decisions on cancer screening and prevention, palliative care, supportive oncology, and quality-of-life issuesNow packaged with FREE access to Cancer: Principles & Practice, 10th Edition on the NEW and ENHANCED LWW Health Library
Oncology Collection. The high-quality, updated content you've come to rely on throughout your career, just got better! Now access Cancer: Principles & Practice, 10th Edition entire content on the go, and access quarterly updates.Additionally, for the first 6 months, Cancer: Principles & Practice of Oncology, 10th Edition purchasers will get access to the entire Oncology Collection on LWW Health Library - an incredible value at no additional charge! Select references are available in the print book. ALL REFERENCES FOR DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 10th edition ARE AVAILABLE ONLINE AT LWWHealthLibrary.com/oncology.
Description based on publisher supplied metadata and other sources.
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2018. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
著者標目 *DeVita Jr., Vincent T
Lawrence, Theodore S
Rosenberg, Steven A
Rosenberg, Steven A
件 名 LCSH:Tumors
FREE:Electronic books
分 類 LCC:RC261.C274 2015
DC:616.99/4
資料種別 機械可読データファイル
巻冊次 ISBN:9781496324672
XISBN:9781451192940